Authors: Mary A. Williamson Mt(ascp) Phd,L. Michael Snyder Md
Normal range:
see Table 16.69.
TABLE 16–69. Normal Range
Use
Monitoring patients with a history of prostate cancer as an early indicator of recurrence and response to treatment
Prostate cancer screening
Interpretation
Increased In
*
Prostate diseases
Cancer
Prostatitis, five to seven times
Benign prostatic hyperplasia
Prostatic ischemia
Acute urinary retention five to seven times
Manipulations